Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

BIT's 3rd Annual World Congress and EXPO of Advanced Materials-2014  (WCAM2014)

06 Jun 2014 - 09 Jun 2014 - Chongqing, China

Bookmark and Share

    WCAM-2014 with the Theme of “Dream of Ubiquitous Smartness” will be held at Chongqing Yuelai International Conference & EXPO Center, China during June 6-9, 2014. It is intended to provide a platform for professionals around the world to exchange state-of-the-art research and development and identify research needs and opportunities in this emerging field.
      As the cornerstone of high-tech industry of the twenty-first century, Advanced Materials are even known as the "cradle" of new technologies, new products, and new equipment of all areas in a sense and will create a huge composite materials market on renewable energy. Based on its significance, WCAM will bring about enormous benefits as well as open up a new and broader pathway for information and experience exchange between China and the rest of the world.
        Keynote Speakers:
          Dr. Dan Shechtman, Philip Tobias Professor of Materials Science, Israel Institute of Technology, Israel. The Nobel Prize in Chemistry 2011
            Dr. Navin Manjooran, Global Manager, Siemens Corporation, USA
              Dr. Florian Kongoli, CEO, FLOGEN Technologies Inc., USA
                Dr. Marek Kozlowski,  Professor, Wroclaw University of Technology, Poland
                  Dr. Zhifeng Ren, M. D. Anderson Chair Professor, Department of Physics and TcSUH, University of Houston, USA Top 100 Materials Scientists
                    Dr. Young-Woo Heo, Dean, School of Materials Science and Engineering, Kyungpook National University, Korea Top 100 Materials Scientists

                      Further information
                      Scientific News
                      Integrated Omics Analysis
                      Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
                      Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
                      Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
                      Salford Lung Study - The First Real World Clinical Trial
                      In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
                      Point of Care Diagnostics - A Cautious Revolution
                      Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
                      Mass Spec Technology Drives Innovation Across the Biopharma Workflow
                      With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
                      Structure of Primary Cannabinoid Receptor is Revealed
                      The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
                      Illumina Contributes to ClinVar Database
                      The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
                      Overlooked Molecules Could Revolutionise our Understanding of the Immune System
                      Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
                      Study Finds Key Regulator in Pulmonary Fibrosis
                      Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
                      Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
                      Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
                      Scroll Up
                      Scroll Down
                      Skyscraper Banner

                      Skyscraper Banner
                      Go to LabTube
                      Go to eposters
                      Access to the latest scientific news
                      Exclusive articles
                      Upload and share your posters on ePosters
                      Latest presentations and webinars
                      View a library of 1,800+ scientific and medical posters
                      3,500+ scientific and medical posters
                      A library of 2,500+ scientific videos on LabTube
                      5,100+ scientific videos
                      Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!